Polymorphisms | Adjusted OR for age and gender (95% CI)/p | |||
---|---|---|---|---|
Tumor size (≥5 cm) | Differentiated status (poorly) | Clinical stage (III-IV) | Metastasis (yes) | |
rs1016343C/T | 0.82(0.59-1.13)/0.22 | 1.05(0.72-1.55)/0.79 | 1.07(0.77-1.49)/0.70 | 1.27(0.91-1.78)/0.16 |
rs13252298A/G | 1.07(0.75-1.52)/0.72 | 1.21(0.80-1.82)/0.37 | 0.85(0.59-1.21)/0.36 | 0.76(0.53-1.10)/0.15 |
rs7007694T/C | 0.74(0.51-1.08)/0.11 | 0.46(0.28-0.77)/0.003 | 1.04(0.71-1.51)/0.85 | 1.11(0.76-1.62)/0.59 |
rs16901946A/G | 0.84(0.59-1.22)/0.36 | 0.59(0.37-0.94)/0.03 | 1.09(0.76-1.58)/0.64 | 1.26(0.87-1.83)/0.22 |
rs1456315A/G | 1.56(1.10-2.23)/0.01 | 1.54(1.03-2.31)/0.04 | 1.16(0.81-1.66)/0.43 | 1.06(0.73-1.52)/0.77 |